You are looking for :
9 results
  • 11/09/2012
    MEPs tighten up drug safety / EU funds for Danish shipyard and Spanish construction workers / MEPs demand that investigations into CIA activities go faster.
  • 11/09/2012
    After the scandal of the Mediator drug, which is thought to have killed hundreds, MEPs demand much stricter safety rules. We talk to the member who wrote the report.
  • 08/05/2012
    The Mediator scandal, where potentially fatal pills remained on the market, highlighted loopholes in EU law. MEPs are voting on stricter pharmaceutical controls.
  • 23/09/2010
    An historic moment for financial supervision. Council President Van Rompuy was in the hot seat. Pharmacovigilance goes 2.0.
  • 22/09/2010
    New EU and national websites will be set up so patients can report side effects of drugs to avoid the needless deaths of hundreds of thousands citizens each year.
  • 27/04/2010
    Europe’s fake drug market is worth 10.5 billion euros according to Pfizer. MEPs want to crack down on the online pharmacies that sell them. No-one can guarantee zero risk when taking licensed drugs, but MEPs want to ensure that side effects are kept to a minimum. Europe is in economic crisis, so why have so many Member States delayed implementation of the services directive, which its supporters say could create 600,000 jobs?
  • 27/04/2010
    Though drugs go through rigorous testing, not all possible side-effects can be avoided. The European Parliament's Environment Committee today looked into pharmacovigilance: the ways of avoiding as far as possible all unpleasant side-effects.
  • 22/04/2010
    We take a look at MEPs' packed agenda for next week, and spend a day with two German MPs who have come to town to explore co-operation with the European Parliament as mandated by the Lisbon Treaty.
  • 22/04/2010
    The last week of April is a busy one in the Parliament, with a round table discussion on a Common European Asylum Policy, reports on safer drugs and the prevention of air accidents, and a public hearing on exotic financial instruments. On the other hand, the vote on Jean-Paul Gauzès’ report about alternative investments has been postponed until 10 May.